Mesothelioma Hope Marks National Cancer Research Month With Latest Advances in Mesothelioma Treatment and Diagnostics
New data from the CheckMate 743 trial, FDA-approved immunotherapy combinations, and emerging therapies are offering renewed hope to mesothelioma patients and families. CHESTNUT HILL, MA / ACCESS Newswire / May 26, 2026 / Mesothelioma Hope, a leading online resource providing education, patient advocacy, and support for those diagnosed with mesothelioma, is recognizing National Cancer Research…